Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.
Center for Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Transplantation. 2019 Apr;103(4):798-806. doi: 10.1097/TP.0000000000002359.
Among kidney transplant recipients, gender differences in medication adherence may contribute to higher graft failure risks observed in girls and young women compared with boys and young men. Our aim was to determine whether adherence differs by gender, and whether gender differences vary by age in adolescent and young adult kidney transplant recipients.
We examined data from the 3-month run-in period (no intervention) of the randomized Teen Adherence in Kidney transplant Effectiveness of Intervention trial. Adherence was monitored using electronic pillboxes in 136 patients (11-24 y) followed in 8 transplant centers in Canada and the United States. We used ordinal logistic regression with generalized estimating equations to estimate the association between gender and each of daily taking (proportion of prescribed doses taken) and timing (proportion of prescribed doses taken on time) adherence, considering effect modification by age (11-16 y vs 17-24 y).
No difference in taking adherence was observed by gender among participants aged 11 to 16 years (odds ratio [OR], 0.92; 95% confidence interval [CI], 0.55-1.54), whereas among participants aged 17 to 24 years, women had significantly greater odds of higher taking adherence scores (OR, 3.03; 95% CI, 1.20-7.66) than men. Results were similar for timing adherence, with no difference among participants aged 11 to 16 years (OR, 1.03; 95% CI, 0.65-1.63) but a greater odds of higher timing adherence scores in women than in men among participants aged 17 to 24 years (OR, 3.26; 95% CI, 1.43-7.45). There were no differences in adherence assessed by self-report or SD of tacrolimus trough levels.
Gender differences in adherence vary by age. Whereas younger adolescents show no adherence differences by gender, young women show much better adherence than young men.
在接受肾移植的患者中,性别差异导致的药物依从性可能会导致女孩和年轻女性的移植物失败风险高于男孩和年轻男性。我们的目的是确定性别是否存在差异,以及在青少年和年轻成年肾移植受者中,性别差异是否因年龄而异。
我们检查了随机青少年肾移植干预效果试验 3 个月导入期(无干预)的数据。在加拿大和美国的 8 个移植中心,通过电子药盒监测了 136 名(11-24 岁)患者的依从性。我们使用广义估计方程的有序逻辑回归来估计性别与每天服用(服用规定剂量的比例)和按时服用(按时服用规定剂量的比例)依从性之间的关联,同时考虑年龄(11-16 岁与 17-24 岁)的效应修饰。
在年龄为 11 至 16 岁的参与者中,性别对服用依从性没有差异(比值比[OR],0.92;95%置信区间[CI],0.55-1.54),而在年龄为 17 至 24 岁的参与者中,女性的服用依从性评分较高的可能性明显高于男性(OR,3.03;95% CI,1.20-7.66)。在按时服用依从性方面,结果相似,年龄为 11 至 16 岁的参与者之间没有差异(OR,1.03;95% CI,0.65-1.63),但年龄为 17 至 24 岁的参与者中,女性的按时服用依从性评分高于男性(OR,3.26;95% CI,1.43-7.45)。通过自我报告或他克莫司谷浓度的标准差评估的依从性没有差异。
依从性的性别差异因年龄而异。虽然年轻的青少年在性别上没有依从性差异,但年轻女性的依从性明显优于年轻男性。